New injection aims to tame stubborn autoimmune diseases
NCT ID NCT07132112
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests an injection called GT719 in 30 people with moderate to severe autoimmune diseases like lupus that haven't responded to standard treatments. The main goal is to check safety and find the right dose, while also looking at whether it helps control disease activity. Participants will be monitored closely for side effects and any improvement in their condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTO IMMUNE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of Nantong University
RECRUITINGNantong, Jiangsu, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new biologic tame lupus flares?
- Could a single injection tame lupus and Sjögren's?
- Can a single infusion tame tough lupus?
- Immune clues in the blood may foretell heart trouble
- Can a simple blood test unlock the secrets of brain autoimmune diseases?
- Can a single drug calm three different autoimmune diseases? a new trial puts ATG-201 to the test.